ArticleJournal of nanobiotechnology2025

Delivery of an ERK inhibitor using bioactive lipid nanoparticles reduces angiogenesis and prevents oral squamous cell carcinoma development.

Zixian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.